Loading organizations...
Moneta Health delivers an AI-powered, phone-based cognitive rehabilitation therapy, structured as an at-home memory program. This program enhances memory, focus, and communication for individuals. Leveraging artificial intelligence, it provides scalable, evidence-based brain health solutions, addressing mild cognitive impairment and early dementia via accessible treatment.
Paul Campbell, a serial healthtech entrepreneur, and bioengineer Jen Flexman, PhD, co-founded Moneta Health, recognizing a critical need for accessible cognitive care. They developed an early-intervention Alzheimer's treatment to address limited access to proven therapies amid increasing cognitive decline. The company gained industry recognition since at least 2023.
Moneta Health primarily serves individuals with mild cognitive impairment or early dementia, supporting their families and caregivers. Its long-term vision focuses on broadening access to effective cognitive care, especially in underserved areas, enabling aging in place. The company aims to redefine cognitive rehabilitation therapy via its innovative platform, fostering improved brain health.
Moneta Health has raised $7.0M across 2 funding rounds.
Moneta Health has raised $7.0M in total across 2 funding rounds.
Moneta Health has raised $7.0M in total across 2 funding rounds.
Moneta Health's investors include 8090 Industries, True Ventures.
Moneta Health has raised $7.0M across 2 funding rounds. Most recently, it raised $5.0M Seed in February 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2025 | $5M Seed | — | 8090 Industries, True Ventures | Announced |
| Feb 1, 2023 | $2M Seed | — | 8090 Industries, True Ventures | Announced |
Moneta Health is a brain health technology company delivering evidence-based cognitive rehabilitation therapy via telephone, blending licensed therapists with an AI-powered voice assistant named Mona to treat mild cognitive impairment (MCI) and early dementia.[1][2][3] It serves older adults in underserved areas, particularly "neurology deserts" like rural regions, solving access barriers through phone-based delivery that requires no apps, internet, or travel; the program improves cognitive function by an average of 18%—surpassing the 13% national benchmark for traditional therapy—and is covered by Medicare, TRICARE, and plans like Aetna and Humana.[3][5] Available in states including Florida, Nevada, Montana, Washington, and West Virginia, Moneta has raised $4.5M from investors like True Ventures, Health2047, and BKR Capital, fueling partnerships such as with Benefis Health System and expansion plans.[3][6]
The company targets the 20-32 million U.S. older adults with cognitive impairment amid provider shortages, emphasizing early intervention to preserve independence and support overburdened neurologists.[2][5] Growth momentum includes clinical outcomes presented at the 2025 Alzheimer's Association International Conference (AAIC), selection for StartUp Health's Alzheimer's Moonshot, and a Mass Digital Health Healthy Aging Challenge finalist spot.[2][4][5]
Moneta Health was co-founded by CEO Paul Campbell, a serial healthtech entrepreneur, and COO Jen Flexman, PhD, a bioengineer, who combined their expertise to address cognitive decline in aging populations.[6] The idea emerged from recognizing a neurologist shortage in 40 U.S. states, cultural resignation to cognitive decline, and the need for scalable, evidence-based interventions like cognitive rehabilitation therapy—proven to preserve function but inaccessible due to provider limits.[4] Early traction came via phone-based delivery for rural and underserved users, validating the "old school meets new school" model of human therapists plus AI.[2]
Pivotal moments include Medicare reimbursement eligibility, expansion to multiple states, and the $4.5M raise announced in September 2025 with a Benefis Health System partnership in Montana, the sixth-oldest state demographically.[3] Participation in StartUp Health's Alzheimer's Moonshot and AAIC presentations further accelerated momentum, humanizing the mission through patient stories like Bryan, who regained confidence to celebrate his 65th birthday.[2][5][6]
Moneta Health rides the aging population wave, where 32% of U.S. adults over 65 face cognitive impairment amid a neurologist shortage, driving demand for scalable telehealth in brain health.[2][5] Timing aligns with AI advancements in voice tech and post-pandemic telehealth normalization, plus Medicare's support for virtual behavioral therapies, enabling national expansion from initial states.[1][3] Market forces like growing Alzheimer's prevalence (20M+ affected) and insurer reimbursements favor its model, relieving neurologists while filling gaps in traditional outpatient care.[2][3]
It influences the ecosystem by pioneering AI-assisted cognitive rehab as a standard, evidenced by Moonshot inclusion, health system integrations, and challenges like Mass Digital Health, potentially shifting care from reactive to proactive for millions in underserved areas.[4][6]
Moneta Health is poised to dominate accessible brain health with national rollout, more health system partnerships, and real-world evidence expansion to solidify its 18% efficacy edge.[3][4] Trends like AI scaling in telehealth, aging demographics, and value-based care will propel growth, evolving its influence from niche provider to ecosystem shaper in cognitive aging. As neurology deserts persist, Moneta's phone-AI blend could redefine standards, empowering older adults to "think, feel, and function at their best."[1][5]
